These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Disease-modifying agents in rheumatoid arthritis. Lipsky PE Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354 [No Abstract] [Full Text] [Related]
9. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis. Clegg DO; Ward JR Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451 [TBL] [Abstract][Full Text] [Related]
10. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments. Simon LS Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of action of disease modifying antirheumatic drugs. Harth M J Rheumatol Suppl; 1992 Jan; 32():100-3. PubMed ID: 1613728 [TBL] [Abstract][Full Text] [Related]
12. Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine. Conaghan PG; Brooks P Curr Opin Rheumatol; 1996 May; 8(3):176-82. PubMed ID: 8796975 [TBL] [Abstract][Full Text] [Related]
13. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials. Dahl SL; Samuelson CO; Williams HJ; Ward JR; Karg M Pharmacotherapy; 1990; 10(2):79-84. PubMed ID: 2112243 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)]. Halberg P Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327 [No Abstract] [Full Text] [Related]
16. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721 [TBL] [Abstract][Full Text] [Related]
17. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis. Galindo-Rodriguez G; Avina-Zubieta JA; Fitzgerald A; LeClerq SA; Russell AS; Suarez-Almazor ME J Rheumatol; 1997 Apr; 24(4):633-8. PubMed ID: 9101493 [TBL] [Abstract][Full Text] [Related]
18. Drug treatment of rheumatoid arthritis. Brooks PM Aust N Z J Med; 1978; 8 Suppl 1():101-5. PubMed ID: 103522 [No Abstract] [Full Text] [Related]
19. Therapeutic approaches to the treatment of rheumatoid disease. St Clair EW; Polisson RP Med Clin North Am; 1986 Mar; 70(2):285-304. PubMed ID: 3512929 [TBL] [Abstract][Full Text] [Related]
20. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs. Harth M; Keown PA; Orange J J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]